JP2022091508A - 感染防止及び消臭洗浄剤、並びに、それを用いた衛生及び生活用品 - Google Patents
感染防止及び消臭洗浄剤、並びに、それを用いた衛生及び生活用品 Download PDFInfo
- Publication number
- JP2022091508A JP2022091508A JP2020204382A JP2020204382A JP2022091508A JP 2022091508 A JP2022091508 A JP 2022091508A JP 2020204382 A JP2020204382 A JP 2020204382A JP 2020204382 A JP2020204382 A JP 2020204382A JP 2022091508 A JP2022091508 A JP 2022091508A
- Authority
- JP
- Japan
- Prior art keywords
- water
- infection
- titanium
- based compound
- deodorant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 129
- 239000002781 deodorant agent Substances 0.000 title claims abstract description 98
- 230000002265 prevention Effects 0.000 title claims abstract description 71
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 131
- 150000001875 compounds Chemical class 0.000 claims abstract description 100
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 82
- -1 titanium phosphate compound Chemical class 0.000 claims abstract description 76
- JUWGUJSXVOBPHP-UHFFFAOYSA-B titanium(4+);tetraphosphate Chemical compound [Ti+4].[Ti+4].[Ti+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O JUWGUJSXVOBPHP-UHFFFAOYSA-B 0.000 claims abstract description 46
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 32
- 239000005017 polysaccharide Substances 0.000 claims abstract description 32
- 239000000243 solution Substances 0.000 claims abstract description 32
- 239000011259 mixed solution Substances 0.000 claims abstract description 20
- 229920000642 polymer Polymers 0.000 claims abstract description 14
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 12
- 239000004094 surface-active agent Substances 0.000 claims abstract description 12
- 125000001453 quaternary ammonium group Chemical group 0.000 claims abstract description 8
- 239000002585 base Substances 0.000 claims abstract description 7
- 239000002245 particle Substances 0.000 claims description 131
- 239000012459 cleaning agent Substances 0.000 claims description 87
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 54
- 230000001877 deodorizing effect Effects 0.000 claims description 34
- 239000002250 absorbent Substances 0.000 claims description 33
- 229920005989 resin Polymers 0.000 claims description 31
- 239000011347 resin Substances 0.000 claims description 31
- 238000006243 chemical reaction Methods 0.000 claims description 30
- 150000004804 polysaccharides Chemical class 0.000 claims description 30
- GNKTZDSRQHMHLZ-UHFFFAOYSA-N [Si].[Si].[Si].[Ti].[Ti].[Ti].[Ti].[Ti] Chemical compound [Si].[Si].[Si].[Ti].[Ti].[Ti].[Ti].[Ti] GNKTZDSRQHMHLZ-UHFFFAOYSA-N 0.000 claims description 29
- 239000004310 lactic acid Substances 0.000 claims description 27
- 235000014655 lactic acid Nutrition 0.000 claims description 27
- 239000004745 nonwoven fabric Substances 0.000 claims description 27
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 claims description 27
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 26
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 26
- 229920000742 Cotton Polymers 0.000 claims description 24
- 239000002759 woven fabric Substances 0.000 claims description 21
- 239000003599 detergent Substances 0.000 claims description 20
- 239000012046 mixed solvent Substances 0.000 claims description 16
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 16
- 239000000126 substance Substances 0.000 claims description 14
- KRDJTDULHZPJPB-UHFFFAOYSA-N titanium(4+);tetraborate Chemical compound [Ti+4].[Ti+4].[Ti+4].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] KRDJTDULHZPJPB-UHFFFAOYSA-N 0.000 claims description 14
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 12
- 230000002378 acidificating effect Effects 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims description 10
- VXEGSRKPIUDPQT-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)piperazin-1-yl]aniline Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=CC(N)=CC=2)CC1 VXEGSRKPIUDPQT-UHFFFAOYSA-N 0.000 claims description 9
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 9
- 239000004327 boric acid Substances 0.000 claims description 9
- 239000005049 silicon tetrachloride Substances 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 8
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 229920002678 cellulose Polymers 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 7
- 235000010980 cellulose Nutrition 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 235000010443 alginic acid Nutrition 0.000 claims description 6
- 239000000783 alginic acid Substances 0.000 claims description 6
- 229920000615 alginic acid Polymers 0.000 claims description 6
- 229960001126 alginic acid Drugs 0.000 claims description 6
- 150000004781 alginic acids Chemical class 0.000 claims description 6
- 229920002988 biodegradable polymer Polymers 0.000 claims description 6
- 239000004621 biodegradable polymer Substances 0.000 claims description 6
- 239000010936 titanium Substances 0.000 claims description 5
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 4
- 229920002581 Glucomannan Polymers 0.000 claims description 4
- 229920002907 Guar gum Polymers 0.000 claims description 4
- 229920000161 Locust bean gum Polymers 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- 235000004298 Tamarindus indica Nutrition 0.000 claims description 4
- 240000004584 Tamarindus indica Species 0.000 claims description 4
- 239000002131 composite material Substances 0.000 claims description 4
- 229940046240 glucomannan Drugs 0.000 claims description 4
- 235000010417 guar gum Nutrition 0.000 claims description 4
- 239000000665 guar gum Substances 0.000 claims description 4
- 229960002154 guar gum Drugs 0.000 claims description 4
- 229920000591 gum Polymers 0.000 claims description 4
- 235000010420 locust bean gum Nutrition 0.000 claims description 4
- 239000000711 locust bean gum Substances 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- 239000001814 pectin Substances 0.000 claims description 4
- 235000010987 pectin Nutrition 0.000 claims description 4
- 229920001277 pectin Polymers 0.000 claims description 4
- 235000010491 tara gum Nutrition 0.000 claims description 4
- 239000000213 tara gum Substances 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 3
- 229920002148 Gellan gum Polymers 0.000 claims description 3
- 229920000569 Gum karaya Polymers 0.000 claims description 3
- 241000934878 Sterculia Species 0.000 claims description 3
- 235000010489 acacia gum Nutrition 0.000 claims description 3
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 235000010492 gellan gum Nutrition 0.000 claims description 3
- 239000000216 gellan gum Substances 0.000 claims description 3
- 235000010494 karaya gum Nutrition 0.000 claims description 3
- 239000000231 karaya gum Substances 0.000 claims description 3
- 229940039371 karaya gum Drugs 0.000 claims description 3
- 229920001515 polyalkylene glycol Polymers 0.000 claims description 3
- 229920002554 vinyl polymer Polymers 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 claims description 2
- 229920013820 alkyl cellulose Polymers 0.000 claims description 2
- 150000002430 hydrocarbons Chemical class 0.000 claims description 2
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 claims description 2
- 229920000058 polyacrylate Polymers 0.000 claims description 2
- 229930195734 saturated hydrocarbon Natural products 0.000 claims description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 59
- 241000233866 Fungi Species 0.000 abstract description 37
- 241000700605 Viruses Species 0.000 abstract description 35
- 239000007864 aqueous solution Substances 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 2
- 239000003792 electrolyte Substances 0.000 abstract 2
- 150000004676 glycans Chemical class 0.000 abstract 2
- 239000000047 product Substances 0.000 description 70
- 230000000694 effects Effects 0.000 description 31
- 230000000844 anti-bacterial effect Effects 0.000 description 30
- 230000002354 daily effect Effects 0.000 description 28
- 239000006185 dispersion Substances 0.000 description 24
- 238000004140 cleaning Methods 0.000 description 23
- 206010046914 Vaginal infection Diseases 0.000 description 20
- 230000000840 anti-viral effect Effects 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- 210000001215 vagina Anatomy 0.000 description 17
- 230000018044 dehydration Effects 0.000 description 16
- 238000006297 dehydration reaction Methods 0.000 description 16
- 230000007062 hydrolysis Effects 0.000 description 16
- 238000006460 hydrolysis reaction Methods 0.000 description 16
- 235000013305 food Nutrition 0.000 description 15
- 239000003242 anti bacterial agent Substances 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- 210000004392 genitalia Anatomy 0.000 description 12
- 238000006482 condensation reaction Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 10
- 230000000843 anti-fungal effect Effects 0.000 description 9
- 206010022000 influenza Diseases 0.000 description 9
- 238000007391 self-medication Methods 0.000 description 9
- 208000035473 Communicable disease Diseases 0.000 description 8
- 206010035664 Pneumonia Diseases 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 8
- 238000002156 mixing Methods 0.000 description 7
- 235000019645 odor Nutrition 0.000 description 7
- 230000001850 reproductive effect Effects 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- 241000222122 Candida albicans Species 0.000 description 6
- 206010007134 Candida infections Diseases 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 206010016952 Food poisoning Diseases 0.000 description 6
- 208000019331 Foodborne disease Diseases 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 201000003984 candidiasis Diseases 0.000 description 6
- 239000012467 final product Substances 0.000 description 6
- 230000009545 invasion Effects 0.000 description 6
- 210000000214 mouth Anatomy 0.000 description 6
- 239000002105 nanoparticle Substances 0.000 description 6
- 239000004155 Chlorine dioxide Substances 0.000 description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 description 5
- 208000002474 Tinea Diseases 0.000 description 5
- 235000019398 chlorine dioxide Nutrition 0.000 description 5
- 238000011109 contamination Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 229920001020 poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) Polymers 0.000 description 5
- 229920001432 poly(L-lactide) Polymers 0.000 description 5
- 229920000070 poly-3-hydroxybutyrate Polymers 0.000 description 5
- 239000004629 polybutylene adipate terephthalate Substances 0.000 description 5
- 239000004631 polybutylene succinate Substances 0.000 description 5
- 229920002961 polybutylene succinate Polymers 0.000 description 5
- 229920009537 polybutylene succinate adipate Polymers 0.000 description 5
- 239000004630 polybutylene succinate adipate Substances 0.000 description 5
- 229920001610 polycaprolactone Polymers 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 230000003449 preventive effect Effects 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 229910010413 TiO 2 Inorganic materials 0.000 description 4
- 241000130764 Tinea Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000002612 dispersion medium Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 101100269850 Caenorhabditis elegans mask-1 gene Proteins 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 3
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 3
- 229920000954 Polyglycolide Polymers 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000019802 Sexually transmitted disease Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000000474 nursing effect Effects 0.000 description 3
- 239000005022 packaging material Substances 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000001528 Coronaviridae Infections Diseases 0.000 description 2
- 208000004145 Endometritis Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- 241001263478 Norovirus Species 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 229910004298 SiO 2 Inorganic materials 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 230000002155 anti-virotic effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000004566 building material Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940014041 hyaluronate Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 208000033808 peripheral neuropathy Diseases 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 229940044977 vaginal tablet Drugs 0.000 description 2
- 239000000003 vaginal tablet Substances 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- RLHGFJMGWQXPBW-UHFFFAOYSA-N 2-hydroxy-3-(1h-imidazol-5-ylmethyl)benzamide Chemical compound NC(=O)C1=CC=CC(CC=2NC=NC=2)=C1O RLHGFJMGWQXPBW-UHFFFAOYSA-N 0.000 description 1
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000084 Abdominal pain lower Diseases 0.000 description 1
- 208000006740 Aseptic Meningitis Diseases 0.000 description 1
- 208000031729 Bacteremia Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 208000033694 Generalised erythema Diseases 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010027201 Meningitis aseptic Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000000450 Pelvic Pain Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002413 Polyhexanide Polymers 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 102100032849 Sentan Human genes 0.000 description 1
- 101710205302 Sentan Proteins 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000006136 alcoholysis reaction Methods 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 230000010065 bacterial adhesion Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000004330 calcium propionate Substances 0.000 description 1
- 235000010331 calcium propionate Nutrition 0.000 description 1
- MCFVRESNTICQSJ-RJNTXXOISA-L calcium sorbate Chemical compound [Ca+2].C\C=C\C=C\C([O-])=O.C\C=C\C=C\C([O-])=O MCFVRESNTICQSJ-RJNTXXOISA-L 0.000 description 1
- 239000004303 calcium sorbate Substances 0.000 description 1
- 235000010244 calcium sorbate Nutrition 0.000 description 1
- 150000001721 carbon Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 201000003511 ectopic pregnancy Diseases 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000018773 low birth weight Diseases 0.000 description 1
- 231100000533 low birth weight Toxicity 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 1
- 229960001019 oxacillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 201000005936 periventricular leukomalacia Diseases 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001699 photocatalysis Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- XJKVPKYVPCWHFO-UHFFFAOYSA-N silicon;hydrate Chemical compound O.[Si] XJKVPKYVPCWHFO-UHFFFAOYSA-N 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229920000247 superabsorbent polymer Polymers 0.000 description 1
- 238000010558 suspension polymerization method Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 235000019669 taste disorders Nutrition 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 208000013464 vaginal disease Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Landscapes
- Absorbent Articles And Supports Therefor (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
Description
<リン酸チタニウム系化合物粒子の調製>
<感染防止及び消臭洗浄剤の調整>
<衛生用品の作製>
<評価>
11 耳掛け部
12 ポケット
13 生分解性を有する高吸水性樹脂が内包されている生分解性不織布製袋
2 ベビー用紙オムツ
21 吸水材
211 吸水紙
212 綿状パルプ
213 高吸水性樹脂
22 防水材
23 表面材
24 漏れ防止立体ギャザー
25 テープ
A おしり
3 アプリケーター式タンポン
31 タンポン
32 取出し紐
33 挿入用外筒
34 押出し用内筒
35 把持部
Claims (20)
- リン酸チタニウム系化合物粒子が純水又は電解水に分散されていることを特徴とする感染防止及び消臭洗浄剤。
- 前記純水が、イオン交換水、蒸留水、逆浸透水、及び、Elix純水のいずれかであり、前記電解水が、弱酸性電解水、微酸性電解水、及び、電解次亜水のいずれかであることを特徴とする請求項1に記載の感染防止及び消臭洗浄剤。
- 水に溶解するアルコールが含有されていることを特徴とする請求項1又は2に記載の感染防止及び消臭洗浄剤。
- 前記アルコールが、メタノール、エタノール、1-プロパノール、1-ブタノール、及び、1-ペンタノールの中から選択される一つ以上であることを特徴とする請求項1~3のいずれか一項に記載の感染防止及び消臭洗浄剤。
- 多糖類及び/又は多糖類のアルカリ金属塩が含有されていることを特徴とする請求項1~5のいずれか一項に記載の感染防止及び消臭洗浄剤。
- 前記多糖類が、セルロース誘導体、微結晶セルロース、アラビアガム、アルギン酸、アルギン酸誘導体、グアーガム、タラガム、ローカストビーンガム、カラギナン、カラヤガム、キサンタンガム、ジェランガム、スクシノグリカン、タマリンドシードガム、ペクチン、寒天、グルコマンナン、デンプン、加工デンプンの中から選択される一つ以上であることを特徴とする請求項5に記載の感染防止及び消臭洗浄剤。
- 第4級アンモニウム塩基を有する高分子及び/又は界面活性剤が含有されていることを特徴とする請求項1~4のいずれか一項に記載の感染防止及び消臭洗浄剤。
- 前記第4級アンモニウム塩基を有する高分子が、第4級アンモニウム塩を有するアクリル系高分子、第4級アンモニウム塩を有するビニル系高分子、及び、第4級アンモニウム塩を有する多糖類誘導体の中から選択されるいずれか一つ以上であり、前記第4級アンモニウム塩を有する界面活性剤が、第4級アンモニウム塩を有する飽和炭化水素化合物及び/又は第4級アンモニウム塩を有するポリアルキレングリコールであることを特徴とする請求項7に記載の感染防止及び消臭洗浄剤。
- 多糖類が含有されていることを特徴とする請求項7又は8に記載の感染防止及び消臭洗浄剤。
- 前記多糖類が、アルキルセルロース、ヒドロキシアルキルセルロース、微結晶セルロース、グアーガム、タラガム、ローカストビーンガム、タマリンドシードガム、ペクチン、グルコマンナン、及び、デンプンの中から選択される一つ以上であることを特徴とする請求項9に記載の感染防止及び消臭洗浄剤。
- 乳酸を含有することを特徴とする請求項1~10のいずれか一項に記載の感染防止及び消臭洗浄剤。
- 前記リン酸チタニウム系化合物粒子が、化学式が、Ti(OH)x(PO4)y(HPO4)z(H2PO4)m(OR)n(Rは炭素数1~4のアルキル基、x,y,z,m,nはそれぞれ0以上の数であり、x+3y+2z+m+n=4を満たす)で表されるリン酸チタニウム系化合物から成ることを特徴とする請求項1~11に記載の感染防止及び消臭洗浄剤。
- 前記リン酸チタニウム系化合物粒子が、四塩化チタンを水と炭素数1~4のアルコールとの混合溶媒と反応させた後、リン酸と反応させて得られる化合物から成ることを特徴とする請求項1~12に記載の感染防止及び消臭洗浄剤。
- 前記リン酸チタニウム系化合物粒子と共に、ケイ酸チタニウム系化合物粒子及びホウ酸チタニウム系化合物粒子の少なくともいずれか一方が混在することを特徴とする請求項1~13のいずれか一項に記載の感染防止及び消臭洗浄剤。
- 前記ケイ酸チタニウム系化合物粒子は、四塩化ケイ素を、水若しくはアルコール、又は、水とアルコールの混合溶液と反応させ、得られた反応溶液に四塩化チタンを添加して反応させることによって調製されたケイ酸チタニウム系化合物から成り、前記ホウ酸チタニウム系化合物粒子は、ホウ酸を水若しくはアルコール、又は、水とアルコールの混合溶液に溶解させ、得られたホウ酸溶液に四塩化チタンを添加して反応させることによって調製されたホウ酸チタニウム系化合物から成ることを特徴とする請求項14に記載の感染防止及び消臭洗浄剤。
- 前記ケイ酸チタニウム系化合物粒子の化学組成がTiO2・SiO2であり、前記ホウ酸チタニウム系化合物粒子の化学組成がTiO2・B2O3であることを特徴とする請求項14又は15に記載の感染防止及び消臭洗浄剤。
- 前記リン酸チタニウム系化合物粒子、前記ケイ酸チタニウム系化合物粒子、及び、前記ホウ酸チタニウム系化合物粒子の平均粒子径が、5~100nmであることを特徴とする請求項1~16のいずれか一項に記載の感染防止及び消臭洗浄剤。
- 請求項1~17のいずれか一項に記載の感染防止及び消臭洗浄剤を、織布、不織布、ガーゼ、綿、スポンジ、及び、高吸水性樹脂、並びに、前記織布、前記不織布、前記ガーゼ、前記綿、前記スポンジ、及び、前記高吸水性樹脂から選択される二つ以上の複合体に含浸させた衛生用品。
- 前記衛生用品の前記織布、前記不織布、前記ガーゼ、前記綿、前記スポンジ、及び、前記高吸水性樹脂が、生分解性高分子を原料として製造されていることを特徴とする請求項18に記載の衛生用品。
- 請求項1~17のいずれか一項に記載の感染防止及び消臭洗浄剤を付着させた生活用品、並びに、衣服及び身の回り品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020204382A JP2022091508A (ja) | 2020-12-09 | 2020-12-09 | 感染防止及び消臭洗浄剤、並びに、それを用いた衛生及び生活用品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020204382A JP2022091508A (ja) | 2020-12-09 | 2020-12-09 | 感染防止及び消臭洗浄剤、並びに、それを用いた衛生及び生活用品 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2022091508A true JP2022091508A (ja) | 2022-06-21 |
Family
ID=82067240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020204382A Pending JP2022091508A (ja) | 2020-12-09 | 2020-12-09 | 感染防止及び消臭洗浄剤、並びに、それを用いた衛生及び生活用品 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2022091508A (ja) |
-
2020
- 2020-12-09 JP JP2020204382A patent/JP2022091508A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI640312B (zh) | 抗微生物之組成物及其製造方法 | |
KR101725175B1 (ko) | 항균 조성물 | |
AU2008281459B2 (en) | Preservative compositions for moist wipes | |
US10905124B2 (en) | Antimicrobial solution and methods of making and using the same | |
WO2002090025A1 (fr) | Procede pour preparer une micropoudre contenant de l'argent nanometrique anti-agglomeration, micropoudre produite par ce procede et son application | |
CN102028705B (zh) | 一种含生物抑菌成分的妇科用品 | |
WO2015054463A1 (en) | Pet deodorizing composition | |
CN101716362A (zh) | 一种含二氧化氯的杀菌消毒材料及其应用 | |
JP2002316909A (ja) | 機能性材料 | |
CN106176322A (zh) | 一种止汗湿巾及其制备方法 | |
JP2004067586A (ja) | 抗菌剤組成物及びそれを用いた抗菌性シート状物品 | |
JP3187676B2 (ja) | 抗菌性ワイパー | |
JP2022091508A (ja) | 感染防止及び消臭洗浄剤、並びに、それを用いた衛生及び生活用品 | |
CN101020072B (zh) | 除臭、抑菌、防霉粉剂 | |
CN101003943A (zh) | 钠米抗菌棉纺织材料及其系列卫生日用品 | |
JPH111700A (ja) | 便座クリーナー用薬剤組成物 | |
JP2015165872A (ja) | 清拭シートおよび清拭シート包装体 | |
CN1644145A (zh) | 一种含单宁酸的无纺布湿巾 | |
CN102871953B (zh) | 一种高吸水性吸附栓剂 | |
CN102613936A (zh) | 一种消毒湿巾及其制备方法 | |
GB2525520B (en) | Water soluble farnesol analogs and their use | |
CN110393672A (zh) | 一种原生态竹纤维无纺布女性用湿巾 | |
CN103707858A (zh) | 一种环保型具有防雾功能的湿巾 | |
CN102860778A (zh) | 适合手口接触的食品消毒湿巾 | |
CN113812421A (zh) | 一种具有抗菌、抗病毒、除螨、止痒等功能的健康型净化剂的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20231108 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20231108 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240130 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240220 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240221 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240423 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240521 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240730 |